News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Applied Genetic Technologies Corporation Expands Its Clinical and Regulatory Expertise with Appointment of Jeffrey Chulay M.D. as Vice President and Chief Medical Officer



7/9/2007 11:02:56 AM

ALACHUA, Fla.--(BUSINESS WIRE)--AGTC (Applied Genetic Technologies Corporation), a privately held clinical stage gene therapy company, is pleased to announce that Dr. Jeffrey Chulay has joined the company as Chief Medical Officer and Vice President of Regulatory Affairs.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES